Response Genetics Regains Compliance with NASDAQ Listing Standards
Response Genetics (NASDAQ: RGDX) announced today that on October 5, 2012, the Company was notified that it has regained compliance with the NASDAQ Capital Market and its minimum market value of listed securities requirement. The Company regained compliance with NASDAQ Marketplace Rule 5550(b)(2) and was notified by NASDAQ that the delisting matter is now closed.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.